KME Trademark

Trademark Overview


On Friday, May 30, 2003, a trademark application was filed for KME with the United States Patent and Trademark Office. The USPTO has given the KME trademark a serial number of 78256313. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, March 9, 2006. This trademark is owned by Athpharma Limited. The KME trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL AND VETERINARY PREPARATIONS IN WHICH THE PHARMACEUTICALLY OR VETERINARILY ACTIVE AGENT IS A KNOWN CHEMICAL ENTITY, NAMELY, NATURAL, SEMI-SYNTHETIC AND SYNTHETIC STEROIDS AND THEIR DERIVATIVES, NON-STEROIDAL ESTROGENS AND MIXTURES THEREOF; A- AND B- ADRENERGIC AGONISTS AND BLOCKERS; ALCOHOL DETERRANTS; ALDOSE REDUCTASE INHIBITORS; NARCOTIC AND NON-NARCOTIC; ANALGESIC ANESTHETICS; ANOREXICS; ANTI-ACNE AGENTS; ANTI ALLERGICS; ANTIANDROGENS AND ANTIESTROGENS; ANTIANGINALS; ANTIARRHYTHMICS; ANTIARTERIOSCLEROTICS; ANTIARTHRITIC/ANTIRHEUMATTCS; ANTIBACTERIAL AGENTS; ANTICONVULSANTS; ANTIDEPRESSANTS; ANTIDIABETICS; ANTIDIARRHEAL AGENTS; ANTIDIURETICS; ANTIFUNGAL AGENTS; ANTIGLAUCOMA AGENTS; ANTIGONADOTROPINS; ANTIHISTAMINES ANTIHYPERLIPOPROTEINEMICS; ANTIHYPERTENSIVE AGENTS; ANTIHYPOTENSIVE AGENTS; NON-STEROIDAL ANTI-INFLAMMATORY AGENTS; ANTIMIGRAINE AGENTS; ANTINAUSEANT AGENTS; ANTINEOPLATICS AGENTS AND ADJUNCTS; ANTIPARKINSONIAN AGENTS; ANTIHYPERPROSTATIC AGENTS; ANTIPURITICS;...

General Information


Serial Number78256313
Word MarkKME
Filing DateFriday, May 30, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, March 9, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 14, 2004

Trademark Statements


Goods and ServicesPHARMACEUTICAL AND VETERINARY PREPARATIONS IN WHICH THE PHARMACEUTICALLY OR VETERINARILY ACTIVE AGENT IS A KNOWN CHEMICAL ENTITY, NAMELY, NATURAL, SEMI-SYNTHETIC AND SYNTHETIC STEROIDS AND THEIR DERIVATIVES, NON-STEROIDAL ESTROGENS AND MIXTURES THEREOF; A- AND B- ADRENERGIC AGONISTS AND BLOCKERS; ALCOHOL DETERRANTS; ALDOSE REDUCTASE INHIBITORS; NARCOTIC AND NON-NARCOTIC; ANALGESIC ANESTHETICS; ANOREXICS; ANTI-ACNE AGENTS; ANTI ALLERGICS; ANTIANDROGENS AND ANTIESTROGENS; ANTIANGINALS; ANTIARRHYTHMICS; ANTIARTERIOSCLEROTICS; ANTIARTHRITIC/ANTIRHEUMATTCS; ANTIBACTERIAL AGENTS; ANTICONVULSANTS; ANTIDEPRESSANTS; ANTIDIABETICS; ANTIDIARRHEAL AGENTS; ANTIDIURETICS; ANTIFUNGAL AGENTS; ANTIGLAUCOMA AGENTS; ANTIGONADOTROPINS; ANTIHISTAMINES ANTIHYPERLIPOPROTEINEMICS; ANTIHYPERTENSIVE AGENTS; ANTIHYPOTENSIVE AGENTS; NON-STEROIDAL ANTI-INFLAMMATORY AGENTS; ANTIMIGRAINE AGENTS; ANTINAUSEANT AGENTS; ANTINEOPLATICS AGENTS AND ADJUNCTS; ANTIPARKINSONIAN AGENTS; ANTIHYPERPROSTATIC AGENTS; ANTIPURITICS; ANTIPSORIATIC AGENTS; ANTIPSYCHOTIC AGENTS; ANTIPYRETICS; ANTISPASMODIC AGENTS; ANTITHROMBOTIC AGENTS; ANTITUSSIVE AGENTS; ANTIULCERATIVE AGENTS; ANTIUROLITHIC AGENTS; ANTIVRAL AGENTS; ANXIOLYTIC AGENTS; BENZODIAZEPINE ANTAGONISTS; BRONCHODILATORS; CALCIUM CHANNEL BLOCKERS; CARDTOTONICS; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS AND REACTIVATORS; CENTRAL NERVOUS SYSTEM STIMULANTS AND AGENTS; DECONGESTANTS; DIURETICS; DOPAMINE RECEPTOR AGONISTS; HEPATIC ENZYME INDUCERS; GASTRIC SECRETION INHIBITORS; GLUCOCORTICOIDS; GONAD-STIMULATING AGENTS AND GONADOTROPIC HORMONES; HEPARIN ANTAGONISTS; HEPATOPROTECTANTS; IMMUNOMODULATORS AND IMMUNOSUPPRESSANTS LH-RH AGONISTS; LIPOTROPIC AGENTS; MINERALOCORTICOIDS; MONOAMINE OXIDASE INHIBITORS; MUCOLYTIC AGENTS; MUSCLE RELAXANTS; NARCOTIC ANTAGONISTS; NEUROPROTECTiVE AGENTS; NOOTROPICAL AGENTS; OPHTHALMIC AGENTS; PERISTALTIC STIMULANTS; PROLACTIN INHIBITORS; PROSTAGLANDINS AND THEIR ANALOGS; PROTEASE INHIBITORS; RESPIRATORY STIMULANTS; SCLEROSING AGENTS; SEDATIVES AND HYPNOTICS; THROMBOLYTIC AGENTS; URICOSURICS; CEREBRAL, CORONARY AND PERIPHERAL VASODILATORS; VASOPROTECTANTS; ANTICOAGULANTS; HEMATINICS; AGENTS FOR BENIGN PROSTATE HYPERTROPHY, MULTIPLE SCLEROSIS AND URINARY INCONTINENCE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 4, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAthpharma Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressBarrymore, Athlone
IE

Party NameAthpharma Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressBarrymore, Athlone
IE

Trademark Events


Event DateEvent Description
Tuesday, May 9, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, May 9, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 13, 2005EXTENSION 1 GRANTED
Thursday, September 1, 2005EXTENSION 1 FILED
Thursday, September 1, 2005TEAS EXTENSION RECEIVED
Friday, May 6, 2005PAPER RECEIVED
Wednesday, November 24, 2004PAPER RECEIVED
Friday, May 6, 2005PAPER RECEIVED
Wednesday, March 9, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 8, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2004PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2004NOTICE OF PUBLICATION
Thursday, October 28, 2004ASSIGNED TO LIE
Thursday, October 7, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 10, 2004ASSIGNED TO LIE
Thursday, September 2, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 15, 2004AMENDMENT FROM APPLICANT ENTERED
Thursday, July 15, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 15, 2004REINSTATED
Wednesday, June 16, 2004FAX RECEIVED
Monday, May 31, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, October 10, 2003NON-FINAL ACTION E-MAILED
Friday, October 10, 2003ASSIGNED TO EXAMINER